机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing, China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
推荐引用方式(GB/T 7714):
Zhou Nan,Yang Lihong,Wei Wenbin.Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma[J].Ophthalmology. Retina.2024,8(12):e48-e48.doi:10.1016/j.oret.2024.05.004.
APA:
Zhou Nan,Yang Lihong&Wei Wenbin.(2024).Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma.Ophthalmology. Retina,8,(12)
MLA:
Zhou Nan,et al."Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma".Ophthalmology. Retina 8..12(2024):e48-e48